MCL1 and melanoma: Moreover, high level of Mcl-1 protein may be associated with melanoma resistance to standard chemotherapeutic agents [13, 20] Thallingher et al. [20] in in vivo study demonstrated that simultaneous dawnregulation of Mcl-1 protein and dacarbazine treatment resulted in enhanced tumor cell apoptosis and significant reduced mean tumor weight.